Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation TCT 2025

Perspective 3: That Could be DanGer-ous: Impella CP is the Way to Go

Presenter: Marwan F. Jumean

October 28, 2025

Presentation TCT 2025

TCT 258: Age and Sex Modify Long-Term Benefit of Microaxial Flow Pump Treatment in Cardiogenic Shock: A DanGer Shock Analysis

Presenter: Anika Klein

October 27, 2025

Presentation TCT 2025

The Contemporary Management of Cardiogenic Shock in the Post DanGer-Shock Era?

Presenter: Jacob Eifer Moeller

October 27, 2025

Presentation TCT 2025

TCT 284: Geographic Disparities in Mechanical Circulatory Support Use Following the DanGer Shock Trial: Insights from the Epic Cosmos Database

Presenter: Karnav Modi

October 27, 2025

Presentation TCT 2025

DanGer Long Term Data ESC: Evidence in the Post DanGer Era

Presenter: Daniel Burkhoff

October 27, 2025

Presentation TCT 2025

TCT 277: Characteristics and Clinical Outcomes of DanGer Shock-Like and Non–DanGer Shock-Like Patients in AMICS Treated With Impella Support: Insights from RECOVER III and NCSI Registries

Presenter: Batla Falah

October 27, 2025

Presentation TCT 2025

TCT 279: Clinical Characteristics of Patients Eligible for the DanGer Shock Trial in a Single-Center ACS Cohort

Presenter: Kohei Osakada

October 27, 2025

Presentation TCT 2025

TCT 272: Escalation of Mechanical Circulatory Support in non-comatose Patients with STEMI-related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial

Presenter: Norman Mangner

October 27, 2025

Presentation TCT 2025

TCT 255: A Novel Cardiogenic Shock Score Based On Danger shock trial

Presenter: Narumi Irie

October 26, 2025

Presentation TCT 2025

TCT 1543: "Arm"ed and (not so) Dangerous: Axillary Artery Impella CP Assisted Left Main PCI

Presenter: Siva Ketha

October 26, 2025

Advertisement

Perspective 3: That Could be DanGer-ous: Impella CP is the Way to Go

TCT 258: Age and Sex Modify Long-Term Benefit of Microaxial Flow Pump Treatment in Cardiogenic Shock: A DanGer Shock Analysis

The Contemporary Management of Cardiogenic Shock in the Post DanGer-Shock Era?

TCT 284: Geographic Disparities in Mechanical Circulatory Support Use Following the DanGer Shock Trial: Insights from the Epic Cosmos Database

DanGer Long Term Data ESC: Evidence in the Post DanGer Era

TCT 277: Characteristics and Clinical Outcomes of DanGer Shock-Like and Non–DanGer Shock-Like Patients in AMICS Treated With Impella Support: Insights from RECOVER III and NCSI Registries

TCT 279: Clinical Characteristics of Patients Eligible for the DanGer Shock Trial in a Single-Center ACS Cohort

TCT 272: Escalation of Mechanical Circulatory Support in non-comatose Patients with STEMI-related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial

TCT 255: A Novel Cardiogenic Shock Score Based On Danger shock trial

TCT 1543: "Arm"ed and (not so) Dangerous: Axillary Artery Impella CP Assisted Left Main PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content